<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>treatment &#8211; Our Story Insight</title>
	<atom:link href="https://www.ourstoryinsight.com/tag/treatment/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.ourstoryinsight.com</link>
	<description>Product that tells our story</description>
	<lastBuildDate>Sat, 25 Oct 2025 12:17:26 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.ourstoryinsight.com/wp-content/uploads/2021/10/Capture-removebg-preview-22-e1635416645194-150x150.png</url>
	<title>treatment &#8211; Our Story Insight</title>
	<link>https://www.ourstoryinsight.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>UK Parliament debates gambling addiction reform and sentencing treatment requirement</title>
		<link>https://www.ourstoryinsight.com/uk-parliament-debates-gambling-addiction-reform-and-sentencing-treatment-requirement/</link>
					<comments>https://www.ourstoryinsight.com/uk-parliament-debates-gambling-addiction-reform-and-sentencing-treatment-requirement/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Fri, 24 Oct 2025 05:30:23 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[addiction]]></category>
		<category><![CDATA[debates]]></category>
		<category><![CDATA[gambling]]></category>
		<category><![CDATA[Parliament]]></category>
		<category><![CDATA[reform]]></category>
		<category><![CDATA[requirement]]></category>
		<category><![CDATA[sentencing]]></category>
		<category><![CDATA[treatment]]></category>
		<guid isPermaLink="false">https://www.ourstoryinsight.com/?p=10185</guid>

					<description><![CDATA[<p>The United Kingdom’s Parliament recently debated the link between gambling addiction and sentencing, considering a new clause that would introduce a “gambling treatment requirement” for offenders. As part of a community order, the proposal states that courts could require offenders to seek treatment for gambling addiction through an National Health Service specialist service, which is [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.ourstoryinsight.com/uk-parliament-debates-gambling-addiction-reform-and-sentencing-treatment-requirement/">UK Parliament debates gambling addiction reform and sentencing treatment requirement</a> appeared first on <a rel="nofollow" href="https://www.ourstoryinsight.com">Our Story Insight</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The United Kingdom’s Parliament recently debated the link between gambling addiction and sentencing, considering a new clause that would introduce a “gambling treatment requirement” for offenders.</p>
<p>As part of a community order, the proposal states that courts could require offenders to seek treatment for gambling addiction through an National Health Service specialist service, which is a potential shift toward recognizing gambling disorder as a mental health issue within the criminal justice system.</p>
<p>The submission made by members of parliament led to the discussion around sentencing reform in general, with the topic of gambling and the NHS, or a professional clinic, mentioned to support those with an agreed condition.</p>
<h2><span id="uk_parliament_discusses_gambling_addiction_reform">UK Parliament discusses gambling addiction reform</span></h2>
<p>The topic “gambling treatment requirement” was centered upon in relation to an order that has been decided through a judicial process. An individual who receives a community order through this process would, as part of the proposed amendments, need to seek clinical support.</p>
<p>“This new clause would introduce a new gambling treatment requirement, requiring an offender to seek NHS gambling addiction treatment as part of a community order,” read the official submission as part of Section 26.</p>
<p>The submission, which was discussed but not approved, put an onus on the UK government to find solutions to support those who would be termed as having a gambling addiction.</p>
<p>There would be pressure on the “Government to report to Parliament on how it will improve support for offenders with gambling addictions and ensure that gambling disorder is recognised as a mental health condition by sentencing court.”</p>
<p>The debate also calls for the Secretary of State to publish a report within six months of the Act passing, explaining how courts will handle gambling disorder as a mental health issue. The report would need to cover access to clinical advice and treatment for offenders, both in prison and in the community. It could be an early move toward linking criminal behavior more directly with mental health and treatment.</p>
<h2><span id="mps_highlight_gambling_issues_and_treatment">MPs highlight gambling issues and treatment</span></h2>
<p>Dr. Alison Gardner, Labor representative from Stoke on Trent, made mention of her own “flutter” with gambling, but then discussed the pitfalls of gambling addiction and its wider impact.</p>
<p>She said, “Problem gambling is associated with not only acquisitive crimes, but street violence, domestic abuse and neglect. That, of course, leads to many harms for the person themselves, their families and the victims of their crimes.”</p>
<p>Assistant Whip and Parliamentary Under-Secretary of State for Justice, Jake Richards, acknowledged Dr. Gardner’s proposals on gambling treatment but disagreed that they should be mandatory, citing pressures on current government systems.</p>
<p>“As I have discussed with her (D. Gardner), there is the issue of the scale of demand and the current lack of any reliable data on how this would look in the criminal justice system.”</p>
<p>Featured image: Canva</p>
<p>The post <a rel="nofollow" href="https://www.ourstoryinsight.com/uk-parliament-debates-gambling-addiction-reform-and-sentencing-treatment-requirement/">UK Parliament debates gambling addiction reform and sentencing treatment requirement</a> appeared first on <a rel="nofollow" href="https://www.ourstoryinsight.com">Our Story Insight</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ourstoryinsight.com/uk-parliament-debates-gambling-addiction-reform-and-sentencing-treatment-requirement/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Trump Lashes Out at Bank of America Over Treatment of Conservatives</title>
		<link>https://www.ourstoryinsight.com/trump-lashes-out-at-bank-of-america-over-treatment-of-conservatives/</link>
					<comments>https://www.ourstoryinsight.com/trump-lashes-out-at-bank-of-america-over-treatment-of-conservatives/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 23 Jan 2025 22:55:40 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[bank]]></category>
		<category><![CDATA[Conservatives]]></category>
		<category><![CDATA[lashes]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[Trump]]></category>
		<guid isPermaLink="false">https://www.ourstoryinsight.com/?p=4871</guid>

					<description><![CDATA[<p>President Trump took an unexpected swipe on Thursday at the big banks that have cheered his return to office, as he raised longstanding Republican complaints that they are discriminated against by major lenders. The moment came almost as an aside, as Mr. Trump was participating virtually in a question-and-answer session with executives gathered at the [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.ourstoryinsight.com/trump-lashes-out-at-bank-of-america-over-treatment-of-conservatives/">Trump Lashes Out at Bank of America Over Treatment of Conservatives</a> appeared first on <a rel="nofollow" href="https://www.ourstoryinsight.com">Our Story Insight</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p></p>
<p class="css-at9mc1 evys1bk0">President Trump took an unexpected swipe on Thursday at the big banks that have cheered his return to office, as he raised longstanding Republican complaints that they are discriminated against by major lenders.</p>
<p class="css-at9mc1 evys1bk0">The moment came almost as an aside, as Mr. Trump was participating virtually in a question-and-answer session with executives gathered at the World Economic Forum in Davos, Switzerland.</p>
<p class="css-at9mc1 evys1bk0">His questioner, Brian T. Moynihan, Bank of America’s chief executive, asked a rote, prepared question about the new administration’s plans for the economy.</p>
<p class="css-at9mc1 evys1bk0">Mr. Trump capped off a nearly two-minute response by observing:</p>
<p class="css-at9mc1 evys1bk0">“By the way, speaking of you — and you’ve done a fantastic job — but I hope you start opening your bank to conservatives, because many conservatives complain that the banks are not allowing them to do business within the bank, and that included a place called Bank of America,” Mr. Trump said.</p>
<p class="css-at9mc1 evys1bk0">He continued, referring to JPMorgan chief executive Jamie Dimon (who was not on the stage), “You and Jamie and everybody, I hope you’re going to open your banks to conservatives, because what you’re doing is wrong.”</p>
<p class="css-at9mc1 evys1bk0">Mr. Moynihan responded with what appeared to be a nervous laugh, and by changing the subject to next year’s World Cup.</p>
<p class="css-at9mc1 evys1bk0">A Bank of America spokesman, Bill Halldin, later said in a statement that the lender never closed accounts for political reasons, but was “required to follow extensive government rules and regulations that sometimes result in decisions to exit client relationships.”</p>
<p class="css-at9mc1 evys1bk0">Mr. Trump’s swerve to the subject was a surprise in the moment, not the least because bankers have been ebullient about his second term, which they hope will touch off an era of profit-making encouraged by relaxed regulations. Yet the topic of political discrimination is a well-trodden one that Mr. Trump occasionally brought up during his campaign.</p>
<p class="css-at9mc1 evys1bk0">For years, conservatives have complained about diversity, equity and inclusion programs at big lenders about the curtailing of investments in fossil fuels and energy; and have accused banks of closing accounts, or debanking, of religious groups.</p>
<p class="css-at9mc1 evys1bk0">Those concerns have been echoed by cryptocurrency backers and prominent venture capitalists who now make up a major bloc of support for Mr. Trump. They were also the subject of a letter last year from Republican attorneys general to Bank of America that said the lender was “responsible for some of the worst-known instances of debanking.” Bank of America replied with a letter denying the accusations.</p>
<p class="css-at9mc1 evys1bk0">In response to complaints of debanking, banking groups generally respond by blaming regulations that require them to flag and automatically close accounts that show suspicious activities associated with money laundering. They point out that complaints about such closures come from customers large and small across the political spectrum.</p>
<p class="css-at9mc1 evys1bk0">A JPMorgan spokeswoman, Patricia Wexler, said that the onus lay with “regulatory ambiguity.”</p>
<p class="css-at9mc1 evys1bk0">“We follow the law and guidance from our regulators and have long said there are problems with the current framework that Washington must address,” she said in a statement.</p>
<p>The post <a rel="nofollow" href="https://www.ourstoryinsight.com/trump-lashes-out-at-bank-of-america-over-treatment-of-conservatives/">Trump Lashes Out at Bank of America Over Treatment of Conservatives</a> appeared first on <a rel="nofollow" href="https://www.ourstoryinsight.com">Our Story Insight</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ourstoryinsight.com/trump-lashes-out-at-bank-of-america-over-treatment-of-conservatives/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Merck says experimental RSV treatment protected infants in trial</title>
		<link>https://www.ourstoryinsight.com/merck-says-experimental-rsv-treatment-protected-infants-in-trial/</link>
					<comments>https://www.ourstoryinsight.com/merck-says-experimental-rsv-treatment-protected-infants-in-trial/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Fri, 18 Oct 2024 04:47:23 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[experimental]]></category>
		<category><![CDATA[infants]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[protected]]></category>
		<category><![CDATA[RSV]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[Trial]]></category>
		<guid isPermaLink="false">https://www.ourstoryinsight.com/?p=3516</guid>

					<description><![CDATA[<p>The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew Kelly &#124; Reuters Merck on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial, bringing the company one step closer to filing [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.ourstoryinsight.com/merck-says-experimental-rsv-treatment-protected-infants-in-trial/">Merck says experimental RSV treatment protected infants in trial</a> appeared first on <a rel="nofollow" href="https://www.ourstoryinsight.com">Our Story Insight</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span class="HighlightShare-hidden" style="top:0;left:0"/></p>
<p>The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021.</p>
<p>Andrew Kelly | Reuters</p>
<p><span class="QuoteInBody-quoteNameContainer" data-test="QuoteInBody" id="RegularArticle-QuoteInBody-1">Merck<span class="QuoteInBody-inlineButton"><span class="AddToWatchlistButton-watchlistContainer" id="-WatchlistDropdown" data-analytics-id="-WatchlistDropdown"><span class="AddToWatchlistButton-addWatchListFromTag"/></span></span></span> on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial, bringing the company one step closer to filing for approval of the shot. </p>
<p>The pharmaceutical giant could emerge as a new competitor in the market for treatments against RSV, which causes thousands of deaths among older Americans and hundreds of deaths among infants each year. Complications from the virus are the leading cause of hospitalization among newborns, making Merck&#8217;s drug a valuable new treatment option if approved.</p>
<p>Merck plans to discuss the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season, according to a release. </p>
<p>The trial examined the safety and efficacy of a single dose of the treatment, clesrovimab, in healthy preterm and full-term infants entering their first RSV season. Merck presented the results at the medical conference IDWeek in Los Angeles.</p>
<p>The treatment reduced RSV-related hospitalizations by more than 84% and decreased hospitalizations due to lower respiratory infections by 90% compared with a placebo among infants through five months, according to Merck. Clesrovimab also reduced lower respiratory infections that required medical attention by more than 60% compared with a placebo through five months.</p>
<p>RSV is a common cause of lower respiratory tract infections such as pneumonia. Results were consistent through both the five-month and six-month time points in the trial, Merck said.</p>
<p>The rates of adverse and serious side effects were comparable between patients who received Merck&#8217;s shot and those who took placebos in the trial. There were no treatment or RSV-related deaths in the study, the company added. </p>
<p>&#8220;These promising results demonstrating decreased incidence of RSV disease, including hospitalizations, highlight the potential for clesrovimab to play an important role in helping to alleviate the continued burden of RSV on infants and their families,&#8221; Dr. Octavio Ramilo, chair of the Department of Infectious Diseases at St. Jude&#8217;s Children&#8217;s Research Hospital, said in Merck&#8217;s release. Ramilo is also an investigator working on the trials. </p>
<p>Merck&#8217;s clesrovimab could potentially compete against a similar treatment from <span class="QuoteInBody-quoteNameContainer" data-test="QuoteInBody" id="RegularArticle-QuoteInBody-6">Sanofi<span class="QuoteInBody-inlineButton"><span class="AddToWatchlistButton-watchlistContainer" id="-WatchlistDropdown" data-analytics-id="-WatchlistDropdown"><span class="AddToWatchlistButton-addWatchListFromTag"/></span></span></span> and <span class="QuoteInBody-quoteNameContainer" data-test="QuoteInBody" id="RegularArticle-QuoteInBody-7">AstraZeneca<span class="QuoteInBody-inlineButton"><span class="AddToWatchlistButton-watchlistContainer" id="-WatchlistDropdown" data-analytics-id="-WatchlistDropdown"><span class="AddToWatchlistButton-addWatchListFromTag"/></span></span></span> called Beyfortus, which was in short supply nationwide last RSV season due to unprecedented demand. Both are monoclonal antibodies, which deliver antibodies directly into the bloodstream to provide immediate protection. </p>
<p>But Merck&#8217;s treatment can be administered to infants regardless of their weight, which the company said may offer convenience in terms of dosing. Meanwhile, the recommended dosage of Beyfortus is based on an infant&#8217;s body weight. </p>
<p>Last year, <span class="QuoteInBody-quoteNameContainer" data-test="QuoteInBody" id="RegularArticle-QuoteInBody-8">Pfizer<span class="QuoteInBody-inlineButton"><span class="AddToWatchlistButton-watchlistContainer" id="-WatchlistDropdown" data-analytics-id="-WatchlistDropdown"><span class="AddToWatchlistButton-addWatchListFromTag"/></span></span></span> and <span class="QuoteInBody-quoteNameContainer" data-test="QuoteInBody" id="RegularArticle-QuoteInBody-9">GSK<span class="QuoteInBody-inlineButton"><span class="AddToWatchlistButton-watchlistContainer" id="-WatchlistDropdown" data-analytics-id="-WatchlistDropdown"><span class="AddToWatchlistButton-addWatchListFromTag"/></span></span></span> rolled out RSV vaccines that are administered to expectant mothers who can pass on protection to their fetuses. </p>
<p>The post <a rel="nofollow" href="https://www.ourstoryinsight.com/merck-says-experimental-rsv-treatment-protected-infants-in-trial/">Merck says experimental RSV treatment protected infants in trial</a> appeared first on <a rel="nofollow" href="https://www.ourstoryinsight.com">Our Story Insight</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ourstoryinsight.com/merck-says-experimental-rsv-treatment-protected-infants-in-trial/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
